XRN Chiron Real Estate Inc.

NYSE · US · Real Estate · REIT - Healthcare Facilities · chironre.com

33.81USD-0.59%Mkt Cap: 489.57M $P/E: 9.09Today

Chiron is a real estate investment trust focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Chiron Real Estate Inc. was establishe…

Industry Peers

REIT - Healthcare Facilities

Omega Healthcare Investors, Inc.

$14.31BUSDP/E 16.2

DOC

Healthpeak Properties, Inc.

$13.36BUSDP/E 53.8

AHR

American Healthcare REIT, Inc.

Healthcare Realty Trust Incorporated

Sabra Health Care REIT, Inc. - Common Stock

$4.89BUSDP/E 73.7

CSH-UN

Chartwell Retirement Residences

$4.80BUSDP/E 1000.0

NHI

National Health Investors, Inc.

$3.19BUSDP/E 18.8

PHP

Primary Health Properties Plc

Medical Properties Trust, Inc.

$1.98BUSD

DHC

Diversified Healthcare Trust - Common Shares of Beneficial Interest

$1.87BUSD

SILA

Sila Realty Trust Inc. Common Stock

$1.68BUSDP/E 44.6

NHP

National Healthcare Properties, Inc. - Class A Common Stock

$1.17BUSD

STRW

Strawberry Fields REIT, Inc. Common Stock

$763.01MUSDP/E 20.8

CPINV

Care Property Invest NV

$550.47MUSDP/E 7.6

Key Statistics

Company

Market Cap489.57M USD

Enterprise Value1.32B USD

Revenue (TTM)153.35M USD

Gross Profit115.06M USD

Net Income (TTM)-5.84M USD

Revenue/Share11.52 USD

Last Price33.81 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees30

CountryUS

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISIN—

Valuation

P/E (Trailing)9.09

P/E (Forward)-8.30

PEG5.09

EV/EBITDA14.30

EV/Revenue8.62

P/S3.21

P/B1.20

EPS (TTM)3.72

EPS (Forward)-4.10

52W Range

29.0550% of range38.54

52W High38.54 USD

52W Low29.05 USD

Profitability

Gross Margin77.91%

Oper. Margin23.17%

EBITDA Margin60.32%

Profit Margin-3.95%

ROE-1.14%

ROA-0.47%

Growth

Revenue Growth4.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF73.61M USD

CapEx (TTM)81.69M USD

FCF Margin61.95%

FCF Yield19.41%

Net Debt624.95M USD

Net Debt/EBITDA6.76

Balance Sheet

Debt/Equity1.31

Current Ratio1.26

Quick Ratio0.95

Book Value/Sh28.42 USD

Cash/Share1.63 USD

Dividends

Fwd Div Rate1.92 USD

Trail. Div Rate2.28 USD

Div. Yield5.65%

5Y Avg Yield9.03%

Payout Ratio145.43%

Ex-Div DateOct 20, 2026

Pay DateDec 18, 2026

Splits

Last Split1:5

Split DateSep 22, 2025

Analyst Consensus

Rating2.3 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)38.56 USD

Upside (mean)+14.0%

Target Range9.000 USD – 46.00 USD

9.000+14.0% to mean46.00

# Analysts9

Ownership

Shares Out.13.24M

Float12.23M

Insiders6.48%

Institutions77.85%

Short Interest

Short Ratio10.5d

Short % Float7.56%

Short % Out.7.13%

Shares Short943.98K

Short (prev mo.)866.76K

Technical

SMA 5036.25 (-6.7%)

SMA 20035.63 (-5.1%)

Beta1.13

S&P 52W Chg14.58%

Avg Vol (30d)97.13K

Avg Vol (10d)102.33K

Technical Indicators

RSI (14)30.9

MACD-0.5216

MACD Signal-0.3149

MACD Hist.-0.2067

BB Upper37.54 USD

BB Middle35.88 USD

BB Lower34.22 USD

BB Width9.26%

ATR (14)0.7890 USD

Vol Ratio (20d)1.01x